Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

SEC MCDC Initiative - Deadline Extension

Publications

August 8, 2014

In June and July, we distributed information regarding the Securities and Exchange Commission's Municipalities Continuing Disclosure Cooperation Initiative (the "MCDC Initiative"). The MCDC Initiative provides issuers and underwriters the opportunity to self-report instances of material misstatements or omissions in bond offering documents regarding the issuer's prior compliance with its continuing disclosure obligations. On July 31, the Securities and Exchange Commission ("SEC") extended the deadline for issuers and obligors to self-report under the MCDC Initiative from September 9, 2014 to 5:00 p.m. EST on December 1, 2014. The deadline for underwriters to self-report remains September 9, 2014.

Issuers should consider discussing with their underwriters any potential reporting involving the issuer prior to the underwriters' deadline. The underwriters are dealing with enormous amounts of information and may not have accurately assessed every issuer's filing and disclosure history. A timely discussion between an issuer and its underwriter may avert an unnecessary filing. Immediately following the underwriters' deadline, issuers should contact their underwriters to identify any reported bond issues and the substance of any reports.

For more information regarding the SEC's July 31 announcement, including the SEC's implementation of a tiered approach to civil penalties for underwriters and a discussion by the SEC of its treatment of those who use good faith efforts to identify certain potential violations, please click here.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.